A detailed history of State Street Corp transactions in Standard Biotools Inc. stock. As of the latest transaction made, State Street Corp holds 1,341,357 shares of LAB stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,341,357
Previous 298,637 349.16%
Holding current value
$2.49 Million
Previous $659,000 451.59%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.87 - $2.78 $1.95 Million - $2.9 Million
1,042,720 Added 349.16%
1,341,357 $3.64 Million
Q4 2023

Feb 14, 2024

BUY
$1.59 - $2.73 $30,369 - $52,143
19,100 Added 6.83%
298,637 $659,000
Q1 2023

May 15, 2023

SELL
$1.3 - $2.24 $2,860 - $4,928
-2,200 Reduced 0.78%
279,537 $545,000
Q3 2022

Nov 15, 2022

SELL
$1.22 - $2.06 $64,782 - $109,386
-53,100 Reduced 15.86%
281,737 $310,000
Q2 2022

Aug 15, 2022

SELL
$1.6 - $3.99 $1.93 Million - $4.8 Million
-1,203,269 Reduced 78.23%
334,837 $536,000
Q1 2022

May 16, 2022

BUY
$2.8 - $3.96 $198,926 - $281,338
71,045 Added 4.84%
1,538,106 $5.52 Million
Q4 2021

Feb 14, 2022

BUY
$3.63 - $6.13 $53,647 - $90,595
14,779 Added 1.02%
1,467,061 $5.75 Million
Q3 2021

Nov 15, 2021

BUY
$5.5 - $7.41 $31,295 - $42,162
5,690 Added 0.39%
1,452,282 $9.57 Million
Q2 2021

Aug 16, 2021

BUY
$4.35 - $6.35 $751,427 - $1.1 Million
172,742 Added 13.56%
1,446,592 $8.91 Million
Q1 2021

May 17, 2021

SELL
$3.94 - $7.09 $161,039 - $289,789
-40,873 Reduced 3.11%
1,273,850 $5.76 Million
Q4 2020

Feb 16, 2021

BUY
$5.45 - $8.65 $371,319 - $589,341
68,132 Added 5.47%
1,314,723 $7.89 Million
Q3 2020

Nov 10, 2020

SELL
$4.34 - $11.43 $245,648 - $646,949
-56,601 Reduced 4.34%
1,246,591 $9.26 Million
Q2 2020

Aug 14, 2020

SELL
$1.85 - $5.29 $154,948 - $443,069
-83,756 Reduced 6.04%
1,303,192 $5.23 Million
Q1 2020

May 11, 2020

BUY
$1.24 - $4.35 $1.72 Million - $6.03 Million
1,386,948 New
1,386,948 $3.52 Million

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $146M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.